Product correctly added to cart.

discount label
Vatinoxan hydrochloride
View 3D

Biosynth logo

Vatinoxan hydrochloride

CAS: 130466-38-5

Ref. 3D-FFA46638

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Tuesday 14 Jan 2025

Product Information

Name:
Vatinoxan hydrochloride
Description:

Vatinoxan hydrochloride is a drug that belongs to the class of α2-adrenergic receptor antagonists. It is used to treat hypertension and congestive heart failure in dogs, cats and horses. Vatinoxan hydrochloride is a potent α2-adrenergic receptor antagonist with clinical relevance for humans. It has been shown to increase plasma glucose levels in anesthetized dogs by acting on cardiac alpha-2 adrenoceptors, which may be responsible for its therapeutic effects in patients with angina pectoris. The pharmacokinetic properties of this drug are not well understood yet, but it has been shown to have similar effects as dobutamine on blood pressure and cardiac function in animals.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
455 g/mol
Formula:
C20H27ClN4O4S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FFA46638 Vatinoxan hydrochloride

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".